Stevens L M, Thompson G K, Fischer A B. "Method for the Synthesis of Empagliflozin Impurity 315" [P]. US Patent, US 10413433 B2, 2018-12-24.
发明人郭海燕,何建平,沈红梅. "A Process for Preparing High-Purity Empagliflozin Impurity 315" [P]. 中国发明专利, 专利号 CN 110606358 B, 授权公告日 2025-08-15.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 恩格列净杂质315 in Pharmaceutical Formulations". Molecules, 2025, 1856, (10), 8802-8828.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩格列净杂质315 as an Impurity". Talanta, 2019, 2110, (10), 6687-6691.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Empagliflozin Impurity 315 Using HRMS and NMR". Sci. Total Environ., 2025, 1114, (3), 7372-7380.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 恩格列净杂质315 Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2010, 1013, 7368-7387.